The level of buy-sell trading at Regeneron Pharmaceuticals is near the 324 member peer company average. The Bio Therapeutic Drugs peer group saw 305 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares per buy/sell trade transacted by Regeneron Pharmaceuticals insiders is higher. Within the peer group there were 32,328,060 shares purchased and 7,189,646 shares sold with company insiders acquiring 126,324 shares on average.
The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
|Insider at Boston Beer (SAM) Makes Significant Sale ...|
|Continued Level of Significant Insider Selling at Fi...|
|SailPoint Technologies Holdings (SAIL) Insider Makes...|
|Continued Level of Significant Insider Selling at Co...|
|Salesforce.com (CRM) Insider Makes Significant Share...|